Antioxidant Activity of Pyrroloquinolinequinol
J. Agric. Food Chem., Vol. 57, No. 2, 2009 455
of hypoxic/ischemic brain injury. Neuroscience 1994, 62, 399–
406.
has, and thus the reduction potentials of the former will be higher
than that of the latter.
(12) Zhang, Y.; Feustel, P. J.; Kimberg, H. K. Neuroprotection by
pyrroloquinoline quinone (PQQ) in reversible middle cerebral
artery occlusion in the adult rat. Brain Res. 2006, 1094, 200–
206.
(13) Hara, H.; Hiramatsu, H.; Adachi, T. Pyrroloquinoline quinone is
a potent neuroprotective nutrient against 6-hydroxydopamine-
induced neurotoxicity. Neurochem. Res. 2007, 32, 489–495.
(14) Van der Meer, R. A.; Groen, B. W.; van Kleef, M. A. G.; Frank,
J.; Jongejan, J. A.; Duine, J. A. Isolation, preparation, and assay
of pyrroloquinoline quinone. Methods Enzymol. 1990, 188, 260–
283, and references are cited therein.
(15) Kumazawa, T.; Sato, K.; Seno, H.; Ishii, A.; Suzuki, O. Levels
of pyrroloquinoline quinone in various foods. Biochem. J. 1995,
307, 331–333.
(16) Stites, T. E.; Mitchell, A. E.; Rucker, R. B. Physiological
importance of quinoenzymes and the o-quinone family of cofac-
tors. J. Nutr. 2000, 130, 719–727.
(17) Kumazawa, T.; Seno, H.; Urakami, T.; Matsumato, T.; Suzuki,
O. Trace levels of pyrroloquinoline quinone in human and rat
samples detected by gas chromatography/mass spectroscopy.
Biochim. Biophys. Acta 1992, 1156, 62–66.
(18) He, K.; Nukada, H.; Urakami, T.; Murphy, M. P. Antioxidant
and pro-oxidant properties of pyrroloquinoline quinone (PQQ):
implications for its function in biological systems. Biochem.
Pharmacol. 2003, 65, 67–74.
(19) Nishigori, H.; Yasunaga, M.; Mizumura, M.; Lee, J. W.; Iwatsuru,
M. Preventive effects of pyrroloquinoline quinone on formation
of cataract and decline of lenticular and hepatic glutathione of
developing chick embro after glucocorticoid treatment. Life Sci.
1989, 45, 593–598.
(20) Zhang, Y.; Rosenberg, P. A. The essential nutrient pyrroloquino-
line quinone may act as a neuroprotectant by suppressing
peroxynitrite formation. Eur. J. Neurosci. 2002, 16, 1015–1024.
(21) Zhu, B.; Simonis, U.; Cecchini, G.; Zhou, H.-Z.; Li, L.; Teerlink,
J. R.; Karliner, J. S. Comparison of pyrroloquinoline quinone and/
or metoprolol on myocardial infarct size and mitochondrial
damage in a rat model of ischemia/reperfusion injury. J. Cardio-
Vasc. Pharmacol. Ther. 2006, 11, 119–128.
(22) Ohwada, K.; Takeda, H.; Yamazaki, M.; Isogaki, H.; Nakano,
M.; Shimomura, M.; Fukui, K.; Urano, S. Pyrroloquinoline
quinone (PQQ) prevents cognitive deficit caused by oxidative
stress in rats. J. Clin. Biochem. Nutr 2008, 42, 29–34.
(23) Gallop, P. M.; Henson, E.; Paz, M. A.; Greenspan, S. L.; Fluckiger,
R. Acid-promoted tautomeric lactonization and oxidation-reduction
of pyrroloquinoline quinone (PQQ). Biochem. Biophys. Res.
Commun. 1989, 163, 755–763.
(24) Gallop, P. M.; Paz, M. A.; Fluckiger, R.; Henson, E. Is the
antioxidant, anti-inflammatory putative new vitamin, PQQ, in-
volved with nitric oxide in bone metabolism? Connect. Tissue
Res 1993, 29, 153–161.
(25) Miyauchi, K.; Urakami, T.; Abeta, H.; Shi, H.; Noguchi, N.; Niki,
E. Action of pyrroloquinolinequinol as an antioxidant against lipid
peroxidation in solution. Antioxid. Redox Signal. 1999, 1, 547–
554.
(26) Mukai, K.; Kageyama, Y.; Ishida, T.; Fukuda, K. Synthesis and
kinetic study of antioxidant activity of new tocopherol (vitamin
E) compounds. J. Org. Chem. 1989, 54, 552–556.
(27) Mukai, K.; Daifuku, K.; Okabe, K.; Tanigaki, T.; Inoue, K.
Structure-activity relationship in the quenching reaction of singlet
oxygen by tocopherol (vitamin E) derivatives and related phenols.
Finding of linear correlation between the rates of quenching of
singlet oxygen and scavenging of peroxyl and phenoxyl radicals
in solution. J. Org. Chem. 1991, 56, 4188–4192.
(28) Mukai, K.; Tokunaga, A.; Itoh, S.; Kanesaki, Y.; Ohara, K.;
Nagaoka, S.; Abe, K. Structure-activity relationship of the free-
radical-scavenging reaction by vitamin E (R-, ꢀ-, γ-, δ-toco-
pherols) and ubiquinol-10: pH dependence of the reaction rates.
J. Phys. Chem. B 2007, 111, 652–662.
In the present work, it has been found that PQQNa2 is easily
reduced by GSH and Cys in buffer solution (pH 7.4), and results
in PQQH2. Cys is a proteinaceous thiol, and GSH is a major
nonproteinaceous thiol. These thiols exist not only in plasma
but also throughout the cell (37). These facts indicate that PQQ
exists as the reduced form (PQQH2) in a variety of tissues and
plays a role as antioxidant. As described in the Introduction,
PQQ was found in many kinds of fruits and foods and in several
tissues, plasma, and urine of humans and rats (15-17). The
ArO• radical scavenging rate constant (ks) of PQQH2 was found
to be 3-4 orders of magnitude larger than those of Cys, GSH,
and UA and 7.4 times larger than that of Vit C at pH 7.4 in
micellar solution. The results of the present kinetic study suggest
that PQQH2 has high activity for the free radical cavenging (and/
or the tocopherol regeneration) and contributes to the prevention
of oxidative damage in tissues.
ACKNOWLEDGMENT
We are very grateful to Professor Fernado Antunes of the
University of Lisbon for his kind guidance with the experiments
under strictly deaerated and nitrogen-substituted conditions
during his stay in Ehime University. We are also grateful to
Akiko Nitta of Ehime University for her kind help in the early
stage of the measurement of the reaction rates.
LITERATURE CITED
(1) Duine, J. A.; Frank, J. J.; Jongejan, J. A. Glucose dehydrogenase
from Acinetobacter calcoaceticus. A ‘quinoprotein′. FEBS Lett.
1979, 108, 443–446.
(2) Salisbury, S. A.; Forrrest, H. S.; Gruse, W. B. T.; Kennard, O. A
novel coenzyme from bacterial primary alcohol dehydrogenases.
Nature 1979, 280, 843–844.
(3) de Beer, R.; Duine, J. A.; FrankJzn, J.; Westering, J. The role of
pyrrolo-quinoline semiquinone forms in the mechanism of action
of methanol dehydrogenase. Eur. J. Biochem. 1983, 130, 105–
109.
(4) McIntire, W. S. Newly discovered redox cofactors: possible
nutritional, medical, and pharmacological relevance to higher
animals. Annu. ReV. Nutr. 1998, 18, 145–177.
(5) Yamada, M.; Elias, M. D.; Matsushita, K.; Migita, C. T.; Adachi,
O. Escherichia coli PQQ-containing quinoprotein glucose dehy-
drogenase: its structure comparison with other quinoproteins.
Biochim. Biophys. Acta 2003, 1647, 185–192.
(6) Toyota, H.; Mathews, F. S.; Adachi, O.; Matsushita, K. Quino-
hemoprotein alcohol dehydrogenases: structure, function, and
physiology. Arch. Biochem. Biophys. 2004, 428, 10–21.
(7) Killgore, J.; Smidt, C.; Duich, L.; Romero-Chapman, N.; Tinker,
D.; Reiser, K.; Melko, M.; Hyde, D.; Rucker, R. B. Nutritional
importance of pyrroloquinoline quinone. Science 1989, 245, 850–
852.
(8) Steinberg, F. M.; Gershwin, M. E.; Rucker, R. B. Dietary
pyrroloquinoline quinone: growth and immune response in
BALB/c mice. J. Nutr. 1994, 124, 744–753.
(9) Steinberg, F. M.; Stites, T. E.; Anderson, P.; Storm, D.; Chan, I.;
Eghball, S.; Rucker, R. B. Pyrroloquinoline quinone improves
growth and reproductive performance in mice fed chemically
defined diets. Exp. Biol. Med. 2003, 228, 160–166.
(10) Bauerly, K. A.; Storms, D. H.; Harris, C. B.; Hajizadeh, S.; Sun,
M. Y.; Cheung, C. P.; Satre, M. A.; Fascetti, A. J.; Tchaparian,
E.; Rucker, R. B. Pyrroloquinoline quinone nutritional status alters
lysine metabolism and modulates mitochondrial DNA content in
the mouse and rat. Biochim. Biophys. Acta 2006, 1760, 1741–
1748.
(11) Jensen, F. E.; Gardner, G. J.; Williams, A. P.; Gallop, P. M.;
Aizenman, E.; Rosenberg, P. A. The putative essential nutrient
pyrroloquinoline quinone is neuroprotective in a rodent model